A Stanford team is developing a bioscaffold that helps insulin-producing cells get enough oxygen when transplanted for diabetes treatment.
Taking a community-based approach to diabetes could help curb high rates of the disease in less wealthy nations, new research suggests.
The latest type 1 diabetes technology improves the stability of patients' blood sugar levels throughout the day and during sleep, according to a new trial.
A therapy delayed the onset of Type 1 diabetes in at-risk people by about two years, new results from a clinical trial show.
Scientists monitored 106 individuals (some of whom have prediabetes) to see how the condition, and infections, impact immune-and-microbiome-related health.
Results from a multi-center clinical trial show that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes and kidney disease.
Type 1 diabetes starts out as a sneak attack by bad-actor antibodies. But scientists at Stanford and UCSF have developed an early-warning system.
By delivering a drug directly to beta cells, researchers may be able to spur insulin production and potentially develop a diabetes therapy in the future.
Access and cost of insulin is affecting those who need it most, and without major improvements, millions will be without a treatment, a new study suggests.
Scientists find new potential drug targets for heart disease and diabetes, while shedding more light on the genetics of cholesterol, a new study has found.
A study led by a Stanford Business researcher at four schools in Panama explores the best way to persuade kids to drink more water.
Although pioneering scientist Gerald Reaven thought that insulin resistance did not affect the kidney, new research suggests that the story is more complex.
A diabetes program, developed with a Stanford scientist, helps cut costs of diabetes-related health care expenses by $815 per year per person.
A design challenge called Disrupt Diabetes was created and spearheaded by two Stanford seniors — best friends and aspiring doctors who felt that innovations for people with diabetes should bubble up from patients’ daily experiences and priorities.
This video highlights Stanford Health Care's team-based approach to diabetes care. Patient Hazel shares her experience helping to design a treatment plan.
In this final installment of the "Breaking down diabetes" series, physician-researcher Randall Stafford weighs in on a debate about blood sugar levels that relates to drug prices.
